Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Addex, Eubiologics, J&J, Medolife, Menarini, RDIF, Roche, Turn, Ultragenyx.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Aquestive, Avicanna, Betterlife, Beximco, Codiak, Galapagos, Elpiscience, Intravacc, LG, Mitsubishi Tanabe, Probiogen, Salarius, Trigr, Ubiquigent, VBI, Xbiotech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abcellera, Aribio, Azurrx, Bio-Thera, Calliditas, Cardiol, Dermata, GSK, Heron, Inmune, Intra-Cellular, Kuur, Lilly, Lyndra, Meissa, Merck, Moderna, Newron, Oramed, Surface Ophthalmics, Sutro, Takeda, Transgene.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott Laboratories, Aerobiotix, Align Technology, Concert Genetics, Djo, Exact Therapeutics, Fio, GE Healthcare, Genesis Medtech, Glaxosmithkline, Histogen, Hua Medtech Inivata, Integra Lifesciences, Intersurgical, Labminds, Mednax, Mercury Medical, Mobileodt, Nexelis, Obalon Therapeutics, Penumbra, Pfizer, Pressure Biosciences, Preventiongenetics, Relay Medical, Reshape Lifesciences, Sinusys, Solutions in Critical Care, Surgical Directions, Trilliant Surgical, Vizient, Wat Medical.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Lightpoint Medical, Omniguide Holdings, Renegade.bio.

The latest global regulatory news, changes and updates affecting biopharma.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adamis, Aptorum, Arcutis, Astrazeneca, Biocelect, BMS, Daiichi, Eutilex, Haisco, Histogen, Impel, Lytix, Merck, Novo Nordisk, Sobi, Taysha, Terns.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advita, Amryt, Aruvant, Biontech, Brainstorm, Bridgebio, Dinaqor, Eidos, Genevant, Gritstone, Hoth, Immunotech, Kiromic, Lonza, Metrion, Myst, Neuronascent, Neuvogen, Oncorus, Pfizer, Relief, Satellos, Sensorion, Sorrento, T-Cure, Therapeutic Solutions, Turnstone, Viewpoint.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Apnimed, Eloxx, Evelo, Faron, Forma, Jemincare, Ocular, Ocuphire, Seneca, Sumitomo, Dainippon, Synairgen, Theralase, Tris.